Biomarkers: Project update from the GRAPPA 2012 annual meeting

Journal of Rheumatology

Volumn 40, Issue 8, 2013, Pages 1453-1454

  FitzGerald, Oliver ^a   Mease, Philip J ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Caspar; PsA BioDam; Psoriatic arthritis; Radiographic progression

Indexed keywords

BIOLOGICAL PRODUCT; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CLINICAL PROTOCOL; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DRUG INDUSTRY; FINANCIAL MANAGEMENT; HUMAN; JOINT RADIOGRAPHY; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS;

BIOMARKERS; CASPAR; PSA BIODAM; PSORIATIC ARTHRITIS; RADIOGRAPHIC PROGRESSION;

ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; HUMANS; MATRIX METALLOPROTEINASE 3; PREDICTIVE VALUE OF TESTS; SWEDEN;

EID: 84881470642     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130462     Document Type: Conference Paper

References (3)

1. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
2. Helliwell PS, Fitzgerald O, Fransen J, Gladman DD, Kreuger GG, Callis Duffin K, et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis 2013;72:986-91.
3. CaRE Arthritis-Arthritis Research and Education in Canada. Edmonton, Alberta. (Internet. Accessed May 9, 2013.) Available from: http://www. carearthritis.com